Development of Dispersible Vaginal Tablets of Tenofovir Loaded Mucoadhesive Chitosan Microparticles for Anti-HIV Pre-Exposure Prophylaxis.
chitosan
intravaginal
mucoadhesion
sustained release
tenofovir
vaginal tablet
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
02 10 2023
02 10 2023
Historique:
medline:
3
10
2023
pubmed:
1
9
2023
entrez:
1
9
2023
Statut:
ppublish
Résumé
Tenofovir disoproxil fumarate (TDF)-loaded bioadhesive chitosan microparticles (CM) were developed by an emulsification internal gelation technique. Among different batches produced, ECH-4 was found to display a high % entrapment efficiency (68.93 ± 1.76%) and sustained drug release of 88.05 ± 0.38% at 24 h. Solid state characterization of ECH-4 employing DSC and PXRD indicated that the TDF existed in an amorphous state as a solid-solid solution in chitosan. Scanning electron microscopy revealed CM of ECH-4 was spherical in shape with a rough surface topography. Laser scattering analysis using Malvern Master sizer indicated that particle size of ECH-4 was in the range of 0.52 ± 0.10 μm to 284.79 ± 21.42 μm with a surface-mean diameter of 12.41 ± 0.06 μm.
Identifiants
pubmed: 37656937
doi: 10.1021/acs.molpharmaceut.3c00288
doi:
Substances chimiques
Tenofovir
99YXE507IL
Chitosan
9012-76-4
Anti-HIV Agents
0
Vaginal Creams, Foams, and Jellies
0
Tablets
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM